ATS Corporation · TSX:ATS

ATS — ATS Automation Tooling Systems — Investor Day (September 2018)

86 slides from ATS's investor day presentation, Sep 18, 2018

  1. Slide 1: ATS Automation – 2018 Investor Day

    Slide 1: ATS Automation – 2018 Investor Day

    ATS AUTOMATION – 2018 INVESTOR DAY - TSX:ATA

  2. Slide 2: Sonya Mehan

    Slide 2: Sonya Mehan

    SONYA MEHAN Director, Investor Relations & Corporate Communications

  3. Slide 3: ATS Investor Day – Agenda

    Slide 3: ATS Investor Day – Agenda

    ATS Investor Day – Agenda - September 18, 2018 Time Topic Presenter 9:30 am Registration 10:30 am Welcome Sonya Mehan, Director IR & Corp Comm 10:35 am Corporate Strategy Andrew Hider, CEO 11:00 am Life Sciences Chris Hart, President, Life Sciences 11:30 am Services Simon Roberts, SVP Services 11:50

  4. Slide 4: Forward-Looking Statements

    Slide 4: Forward-Looking Statements

    Forward-Looking Statements This presentation and the oral statements made during this meeting contain certain statements that constitute forward-looking information within the meaning of applicable securities laws ("forward-looking statements"). Such forward-looking statements involve known and unkn

  5. Slide 5: Andrew Hider

    Slide 5: Andrew Hider

    ANDREW HIDER Chief Executive Officer

  6. Slide 6: ATS Executive Team

    Slide 6: ATS Executive Team

    ATS Executive Team Andrew Hider Chief Executive Officer Maria Perrella Chris Hart Simon Roberts Jeremy Patten Chief Financial President, Senior Vice President, Global Director, Officer Life Sciences After Sales Services ATS Business Model 6

  7. Slide 7: ATS at a Glance

    Slide 7: ATS at a Glance

    ATS at a Glance ATA TSX $2.2B Market Cap +$1B Revenue 3,800 Employees 20 • Facility Facilities • Office +50 Offices 22 Countries 7 A global technology and automation solutions provider across diverse industrial markets

  8. Slide 8: What We Do

    Slide 8: What We Do

    What We Do Enterprise Systems Innovative Machines Contract Value Products Services & Digitization Degree of Customization Pre-Automation Product / Automation/Integration Post-Automation • Discovery & analysis • Custom automation • Installation • Concept development • Machine build • Commission • Aut

  9. Slide 9: ATS Strategy: Expand, Grow, Build

    Slide 9: ATS Strategy: Expand, Grow, Build

    ATS Strategy EXPAND Broaden our Reach GROW Grow the Core BUILD Build the Foundation ATS Business Model 9 Driving sustainable long-term shareholder value

  10. Slide 10: The ATS Business Model

    Slide 10: The ATS Business Model

    The ATS Business Model 10 Repeatable model to drive performance and growth

  11. Slide 11: The Value Drivers

    Slide 11: The Value Drivers

    The 8 Value Drivers Financial: EBIT Working Bookings Revenue Capital Margin Customer: People: On-Time Internal Fill Employee Quality Delivery Rate Turnover Continuous Improvement 11 Standardized performance measurement across all business units

  12. Slide 12: People

    Slide 12: People

    People People are our number one asset. Our winning culture enables employee:  Engagement  Ownership  Accountability Engineers/Designers  Development  Retention Trades/Assembly  Passion to succeed Employees by Skill Project Managers Other 12 A passion for winning with continuous improvement at

  13. Slide 13: Our Markets

    Slide 13: Our Markets

    Our Markets Consumer & Life Sciences Transportation Energy Electronics Market Size $10B $11B $16B $5B Medical Devices EV/Hybrid Nuclear Personal Care Biotechnology Drive/Transmission Solar Cosmetics Applications Pharmaceuticals Assembly Oil & Gas Durables Chemicals Pumps, Sensors, Steering Brands F1

  14. Slide 14: Growth Platforms

    Slide 14: Growth Platforms

    Growth Platforms A global technology and automation solutions provider across diverse industrial markets Strategic Life Electric New Growth Services Sciences Vehicles Frontiers Platforms • Innovation: differentiated technologies / products • Digital growth: IIOT, serialization, predictive maintenanc

  15. Slide 15: Transportation: EV

    Slide 15: Transportation: EV

    Transportation: EV Pivoting Transportation business to EV Industry shifting towards EV Customers 120 Production CAGR Volume (M)1 100  OEMs 80 EV +MTW 60  Tier 1s Diesel -MSD 40  New EV entrants 20 Gasoline Flat 0  Global 2016 2024 Sub-markets Competitors ATS Alignment Battery / Power  Fragmente

  16. Slide 16: KMW Acquisition

    Slide 16: KMW Acquisition

    KMW Acquisition KMW is an established German provider of micro-assembly systems primarily for the automotive industry. Company Name: Customers: KMW Konstruktion, Maschinen & Werkzeugbau International automotive (OEM & Tier 1) Key Financials: Competitors: Revenues: ~14M Euro Highly fragmented, mainly

  17. Slide 17: Disciplined M&A Approach

    Slide 17: Disciplined M&A Approach

    Disciplined M&A Approach M&A Process Target Qualification: Target Identification Attractive Daily Management and KPIs Markets Target Qualification Ability Strong to Returns Manage Target Pursuit Strategic Transaction Execution Fit 17 Dedicated team to drive proactive target identification, cultivati

  18. Slide 18: Innovation

    Slide 18: Innovation

    Innovation Market ATS Innovation technology Centre leadership Advisory Broaden Council reach/scope oversight Expanded capability Linear Motion Increased profitability Vision Employee IIOT engagement 18 Innovation focused on expanding key capabilities

  19. Slide 19: Fiscal 2018 Overview

    Slide 19: Fiscal 2018 Overview

    Fiscal 2018 Overview Order Bookings* YoY (C$ millions) Order Backlog* YoY (C$ millions) $1,200.0 $1,182.0 $750.0 $746.0 +4% +10% $1,134.0 Improved $681.0 Financial Results $1,000.0 $600.0 2017 2018 2017 2018 Strategic New Deployed Review Customer the ABM Relationships  Operations Total Revenue YoY

  20. Slide 20: Chris Hart

    Slide 20: Chris Hart

    CHRIS HART President, Life Sciences

  21. Slide 21: Life Science Systems Group

    Slide 21: Life Science Systems Group

    Life Science Systems Group Chris Hart President Mike Healy Simon Drexler Blair de Verteuil Tom Hayes Ian Cameron VP Applications & Director Linear VP Operations VP Global Sales Director Innovation Systems Engineering Mover Technology North America 21

  22. Slide 22: Life Science Systems Group: Capacity & Capability

    Slide 22: Life Science Systems Group: Capacity & Capability

    Life Science Systems Group Capacity & Capability Global Facilities Engineers EMPLOYEES: ~850 Assembly Other Revenue (C$ millions) Cambridge Building 2, Canada Sankt Georgen, Germany $350.0 $328.0 Cambridge Building 3, Canada Winnenden, Germany +31% Chicago, USA $250.0 Assembly Floor 425,000 sq ft (4

  23. Slide 23: Life Sciences Market

    Slide 23: Life Sciences Market

    Life Sciences Market Diabetes COPD Aneurysm Today 4,660 Americans will Affects 21.7 million Approx. 6 million people in the be diagnosed with diabetes. Americans. US have a brain aneurysm. Nearly 30 million The fourth leading cause 1 in 15 people will develop a Americans have diabetes. of death, 112

  24. Slide 24: The Treatment – The Devices

    Slide 24: The Treatment – The Devices

    The Treatment – The Devices Diabetes COPD Aneurysm 24

  25. Slide 25: Proven Capabilities: Medical Devices

    Slide 25: Proven Capabilities: Medical Devices

    Proven Capabilities Across Multiple Applications Medical Devices  High Volume Consumables  Auto Injectors  Metered Dose Inhalers  Needle Sets & Assemblies  Micro Needle/Needleless  Combination Devices  Safety Catheters  Specialized Infusion  Counters 25

  26. Slide 26: Proven Capabilities: Pharmaceutical and Ophthalmic

    Slide 26: Proven Capabilities: Pharmaceutical and Ophthalmic

    Proven Capabilities Across Multiple Applications Pharmaceutical Ophthalmic  ASRS Systems  Radiopharmaceutical  Contact Lenses  Patient Order Fulfillment  Vaccine Production  Surgical Instruments  Data Management  Transdermals  Products/Solutions 26

  27. Slide 27: Proven Capabilities: Diagnostic

    Slide 27: Proven Capabilities: Diagnostic

    Proven Capabilities Across Multiple Applications Diagnostic  POC diagnostics  Lab Analysis  Protein & Microfluidic Chips  Hand Held Diagnostics  Material Handling  POC Biosensors  Load/Unload  Marking and Traceability  DNA Microarrays 27

  28. Slide 28: Market Dynamics

    Slide 28: Market Dynamics

    Market Dynamics High Barriers to Entry Secular Growth Drivers Demographics / Environment Regulated Environments Higher incidences of certain ailments and Increasing regulations, safety & compliance development of new treatments & therapies Complex Processes Disposable products Technologically intens

  29. Slide 29: Customer Engagement Model

    Slide 29: Customer Engagement Model

    Customer Engagement Model “The Machine that Builds the Machine” INNOVATION & ATS BUSINESS MODEL (ABM) Systems Products Engineered Build to Print Repetitive Products Systems Equipment Manufacturing The Customer Experience Step1: Engage Step 2: Make Perfect Step 3: Repeat 29 Fundamentals, Consistency,

  30. Slide 30: Customer Engagement Model: Offering

    Slide 30: Customer Engagement Model: Offering

    Customer Engagement Model INNOVATION & ATS BUSINESS MODEL (ABM) Integrated ENTERPRISE LEVEL  Embedded Staff  Multi Vendor Management  Single Work Scopes PROGRAM LEVEL  Long Term Engagement OFFERING  Design and Build  Alignment of Risk/Reward  Build to Print  Build Multiple Work Scopes  TCO

  31. Slide 31: Competitive Landscape

    Slide 31: Competitive Landscape

    Competitive Landscape Fragmented competitor landscape: opportunity to increase ATS share Pre-Automation / Projects / Programs Pharma Prototypes / Projects Programs / Enterprise 31 No clear market leader - ATS among top 5 players

  32. Slide 32: Innovation Strategy

    Slide 32: Innovation Strategy

    Innovation Strategy Linear Motion Vision IIOT Growth Profit Services People Introduce New Products Increase Profitability Build Services Connectivity Enhance Employee to New and Existing Through Purpose Built to Customers and Systems Engagement By Supporting Markets Innovations & Fostering Creativit

  33. Slide 33: Data Analytics – ATS Toolkit

    Slide 33: Data Analytics – ATS Toolkit

    Data Analytics – ATS Toolkit TOOLKIT Manufacturing Intelligence 33

  34. Slide 34: Why ATS Wins

    Slide 34: Why ATS Wins

    Why ATS Wins INDUSTRY LEADING EXTENSIVE TECHNOLOGY KNOWLEDGE BASE 23,000 Programs REAL RESULTS ■ Higher Productivity & Efficiency ■ Faster Time GLOBAL SCALE PROVEN TURNKEY to Market SOLUTIONS ■ Mitigated Risk ■ Quality Solutions 3800 Employees 34 Well positioned to drive growth through proven capabi

  35. Slide 35: Simon Roberts

    Slide 35: Simon Roberts

    SIMON ROBERTS Senior Vice President, After Sales Services

  36. Slide 36: Services Management Team

    Slide 36: Services Management Team

    Services Management Team Simon Roberts SVP, After Sales Services David Hewitt Kevin Jones Laurence Oldacre Global Darko Maldini Global Service Director Global Service Director Service Director, Global Service Director, Life Science EVSA Sales & Marketing Spares 36

  37. Slide 37: Where Do Services Fit?

    Slide 37: Where Do Services Fit?

    Where Do Services Fit? PATIENT DEVICES AUTOMATION SERVICES Life Sciences Example 37 Extending our overall value proposition - Supporting all ATS industrial markets

  38. Slide 38: Why Grow Services?

    Slide 38: Why Grow Services?

    Why Grow Services? Customer Benefits Shareholder Benefits Higher productivity/output Revenue Growth Lower cost of ownership Margin Expansion Longer useful life Recurring Revenue Reduced lead time Customer Loyalty Better risk management Differentiation Optimal resource planning 38 More service, more

  39. Slide 39: Creating Value – Customer Example

    Slide 39: Creating Value – Customer Example

    Creating Value – Customer Example Automation Product: System Injector Pen Assy. $7,000,000 Potential Productivity Improvement $6,000,000 $5,000,000 Pieces/Min Production:100 Unit Cost: 20 $4,000,000 1% OEE 2% OEE $3,000,000 5% OEE $2,000,000 $1,000,000 $0 Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Ye

  40. Slide 40: Services Evolution

    Slide 40: Services Evolution

    Services Evolution Strategic direction: from “Basic Services” to “Smart Services” Today High BENEFIT FOR CUSTOMER Smart Service Services Service Excellence Products Basic 20% of Services Total Sales 10%+ of Digital Transformation Total Sales ~5% of Total Sales Low 40 Develop and leverage emerging di

  41. Slide 41: Where Are We In Our Evolution?

    Slide 41: Where Are We In Our Evolution?

    Where Are We In Our Evolution? Upgrade/Retrofit Spares Kits 24/7 Technical Support Specialized Training Smart Services Reliability Engineering Servitization Preventive Maintenance IoT Tools Service Organization Performance Focused Smart Proactive & Service Reactive & Services Standard Service Excell

  42. Slide 42: Services Portfolio Today

    Slide 42: Services Portfolio Today

    Services Portfolio Today ASSET MANAGEMENT PROGRAMS 42 Lower cost of ownership Better risk mgmt. PRODUCT BASED UPGRADES SYSTEM UPGRADE & Optimal bu pals RETROFIT resource planning useful life Reduced lead time REGULATORY UP! TECHNOLOGY DRIVEN

  43. Slide 43: What Is After Sales Service?

    Slide 43: What Is After Sales Service?

    What Is After Sales Service? Total Life Cycle Support What We Sell Proactive customer engagement Services are aimed at extending traditional asset life-cycle and improving its overall productivity CUSTOMER VALUE Asset Management Programs Traditional Asset Life-Cycle COMMISSIONING WARRANTY LIFE OF IN

  44. Slide 44: What Is After Sales Service? Upgrades

    Slide 44: What Is After Sales Service? Upgrades

    What Is After Sales Service? What We Sell Total Life Cycle Support CUSTOMER VALUE Upgrades Asset Management Traditional Asset Life-Cycle COMMISSIONING WARRANTY LIFE OF INSTALLATION 44

  45. Slide 45: What Is After Sales Service? Spares

    Slide 45: What Is After Sales Service? Spares

    What Is After Sales Service? What We Sell Total Life Cycle Support Spares CUSTOMER VALUE Upgrades Asset Management Traditional Asset Life-Cycle COMMISSIONING WARRANTY LIFE OF INSTALLATION 45

  46. Slide 46: Future Services – Going Digital

    Slide 46: Future Services – Going Digital

    Future Services – Going Digital Real time resource Shorter proposal lead times planning and control Harmonized pricing Real time field intelligence Configure, Field Price, Services Quote Knowledge Customer Management Portal Consolidated Customer engagement platform Customer Self Serve Machine learni

  47. Slide 47: Data Analytics – ATS Toolkit

    Slide 47: Data Analytics – ATS Toolkit

    Data Analytics – ATS Toolkit TOOLKIT Manufacturing Intelligence 47

  48. Slide 48: Where Are We In Our Evolution?

    Slide 48: Where Are We In Our Evolution?

    Where Are We In Our Evolution? IoT Monitoring & Support Be Agile, Ready to Adapt, New Models Full Service Contracts Predictive Service Contracts Service Level Agreements Service on Demand Multi-Vendor Service Integrated Supply Chain Ecommerce Performance Based Contracts Smart Services Yesterday Toda

  49. Slide 49: Go To Market Approach

    Slide 49: Go To Market Approach

    Go To Market Approach Tiered Customer Engagement Model Value EXPAND GROW DEVELOP Number of Customers CAPEX CHANNEL INSTALLED BASE CHANNEL – 23,000 SYSTEMS GLOBALLY  Leverage initial capital equipment sales  Expand existing strategic relationships through Key Account cycle to sell tiered service pa

  50. Slide 50: Delivery Infrastructure

    Slide 50: Delivery Infrastructure

    Delivery Infrastructure • Facility • Office • Service Partners Global team increase over Partnerships with 22 50% in the last 3 years. approved service providers. 50 Global network of ATS facilities and ATS partners

  51. Slide 51: Why Grow Services?

    Slide 51: Why Grow Services?

    Why Grow Services? Customer Benefits Shareholder Benefits Higher productivity/output Revenue Growth Lower cost of ownership Margin Expansion Longer useful life Recurring Revenue Reduced lead time Customer Loyalty Better risk management Differentiation Optimal resource planning 51 More service, more

  52. Slide 52: Jeremy Patten – ATS Business Model

    Slide 52: Jeremy Patten – ATS Business Model

    JEREMY PATTEN ATS Business Model (ABM) Overview & Introduction

  53. Slide 53: ABM Organizational Support

    Slide 53: ABM Organizational Support

    ABM Organizational Support Jeremy Patten Global Director, ABM Kyle Kohn Harald Dörsch North America, Europe, Regional ABM Leader Regional ABM Leader North America, Divisional ABM Champions Europe, Divisional ABM Champions 53

  54. Slide 54: The ATS Business Model (ABM)

    Slide 54: The ATS Business Model (ABM)

    The ATS Business Model (ABM) 54

  55. Slide 55: ABM Phased Approach

    Slide 55: ABM Phased Approach

    ABM Phased Approach ABM Launch ABM Acceleration ABM as our Culture Focus: Problem Solving & Leadership Focus: Commercial Growth Tools & Focus: ABM at Every Level and Every Training; ABM Fundamentals Pace, Depth, and Repetition Function  People: ABM Champions and ABM Team  People: Leader & Talent D

  56. Slide 56: ATS Business Model – The Fundamentals

    Slide 56: ATS Business Model – The Fundamentals

    ATS Business Model – The Fundamentals  Value-Added vs. Non-Value-Added  Waste “muda”  Kaizen  5S  Problem Solving  Gemba Leadership 56 Lean methodologies, evolving since the early 1900’s… the ABM is about execution every day

  57. Slide 57: ABM Core Concepts: Value

    Slide 57: ABM Core Concepts: Value

    ABM Core Concepts: Value VALUE NON-VALUE ADDED ACTIVITIES: ADDED ACTIVITIES: Those process steps that take Any process or operation time, resources, or space, but that shapes or transforms a do not transform or product or service shape the product into a final form that the or service towards that w

  58. Slide 58: ABM Core Concepts: Waste

    Slide 58: ABM Core Concepts: Waste

    ABM Core Concepts: Waste Muda = “Waste”  Type 1 Muda – Necessary Waste  Type 2 Muda – Unnecessary Waste 58

  59. Slide 59: ABM Core Concepts: Fundamentals

    Slide 59: ABM Core Concepts: Fundamentals

    ABM Core Concepts: Fundamentals A continuous improvement mindset; Kaizen  Kaizen Event: 3-5 Days using ABM Tool Problem Data-Driven, Methodical, and Process-based Solving Root Cause Analysis and Actions (PDCA) Gemba Servant Leaders at all levels Leadership Everything has a spot, everything in its s

  60. Slide 60: ABM In Motion

    Slide 60: ABM In Motion

    ABM In Motion… 1S - Sort • Keep only what is required 5S – Sustain • Sort “Bad” from “Good” Training and discipline. 4S - 2S – Set to Standardize Order • Standardize the best practices • Everything has a space and in the work area. everything in it’s space • Maintain high standards in workplace orga

  61. Slide 61: Engagement with ABM

    Slide 61: Engagement with ABM

    Engagement with ABM ABM – Drives Business ABM – Drives Individual Performance Performance ABM – Drives ABM – Drives Customer Innovation and Future and Shareholder Value Value Creation ABM – Drives Employee Engagement and Empowerment 61

  62. Slide 62: ABM For Results – Life Sciences Quoting

    Slide 62: ABM For Results – Life Sciences Quoting

    ABM For Results – Life Sciences Quoting Before Kaizen Results  Global Life Science Implement Daily Management Quoting Process  Average Time to Quote 11-12 Days Cambridge Winnenden Average decrease from 10-12 days to 5 days, ~50%. 62 Implication: more quoting capacity directly supports profitable g

  63. Slide 63: ABM For Results – sortimat Receiving

    Slide 63: ABM For Results – sortimat Receiving

    ABM For Results – sortimat Receiving Before Kaizen Results  US sortimat Receiving Kaizen Receiving Flow  Receiving > 24 hrs Receiving 100% < 24 hrs;  Avg time to kit > 11min/part 50% Improvement Avg Time To Kit 11 min  5 min / part Team and Line-Level Engagement All Shipping Receiving Inside “Ca

  64. Slide 64: ABM Journey

    Slide 64: ABM Journey

    ABM Journey People Year One Year Two  Global Director ABM  ABM Commercial Leader: Growth Tools  ABM North America & Europe Regional Ldrs  Develop Leaders on “ABM as a Culture”  ABM Champion Assigned in Each Division Process  100% Leadership Trained  ABM Assessment Tool & Roadmaps  2 Formal A

  65. Slide 65: ATS Automation – 2018 Investor Day

    Slide 65: ATS Automation – 2018 Investor Day

    ATS AUTOMATION – 2018 INVESTOR DAY - TSX:ATA

  66. Slide 66: ATS Investor Day – Agenda

    Slide 66: ATS Investor Day – Agenda

    ATS Investor Day – Agenda - September 18, 2018 Time Topic Presenter 9:30 am Registration 10:30 am Welcome Sonya Mehan, Director IR & Corp Comm 10:35 am Corporate Strategy Andrew Hider, CEO 11:00 am Life Sciences Chris Hart, President, Life Sciences 11:30 am Services Simon Roberts, SVP Services 11:50

  67. Slide 67: ATS Automation – 2018 Investor Day

    Slide 67: ATS Automation – 2018 Investor Day

    ATS AUTOMATION – 2018 INVESTOR DAY - TSX:ATA

  68. Slide 68: Customer Success Story: Insulet Corporation

    Slide 68: Customer Success Story: Insulet Corporation

    Customer Success Story: Insulet Corporation Customer Guest Speaker: Chuck Alpuche EXPAND Executive Vice President/ Chief Operations Officer Global Operations, Distribution, Procurement, R&D and Program Management.  NASDAQ:PODD  Innovative medical device company  Reduces burden  HQ: Massachusetts

  69. Slide 69: Maria Perrella

    Slide 69: Maria Perrella

    MARIA PERRELLA Chief Financial Officer

  70. Slide 70: Order Bookings and Order Backlog

    Slide 70: Order Bookings and Order Backlog

    Order Bookings and Order Backlog Order Bookings* ($millions) Order Backlog* ($millions) 1,250 800 700 1,000 600 500 750 400 300 500 200 100 250 0 F2014 F2015 F2016 F2017 F2018 F2014 F2015 F2016 F2017 F2018 Consumer Products & Electronics Energy Transportation Life Sciences • 4% increase in F2018 • 1

  71. Slide 71: Revenues, Margins, EPS

    Slide 71: Revenues, Margins, EPS

    Revenues, Margins, EPS Revenues & Operating Margins Earnings per Share ($millions) $ 300 0.25 15% 250 0.20 10% 0.15 200 5% 0.10 150 0.05 100 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 0.00 FY17 FY18 FY19 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Revenue Adjusted Earnings from Operations %* FY17 FY18 FY19 Earnings from Operatio

  72. Slide 72: Working Capital & Capex

    Slide 72: Working Capital & Capex

    Working Capital & Capex Non-Cash Working Capital as a % of Revenue* Historical Capital Expenditures (C$ millions) Capex % of Revenue 20% 30 $26 15% 20 $18 10% $16 5% 10 2.3% 1.8% 0% 1.5% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 0 FY 17 FY 18 FY 19 FY 16 FY 17 FY 18  Target below 15%  Low capital spend  Structu

  73. Slide 73: Return on Invested Capital

    Slide 73: Return on Invested Capital

    Return on Invested Capital 12.00% Target:  ROIC > WACC 10.00% 8.00% Levers:  Growth 6.00%  Margin expansion  Capital deployment 4.00% 2.00% 0.00% TTM-Q1 TTM-Q2 TTM-Q3 TTM-Q4 TTM-Q1 TTM-Q2 TTM-Q3 TTM-Q4 TTM-Q1 FY17 FY17 FY17 FY17 FY18 FY18 FY18 FY18 FY19 ROIC (TTM) 7.85% 7.13% 6.04% 7.04% 7.03% 7

  74. Slide 74: Margin Expansion

    Slide 74: Margin Expansion

    Margin Expansion Commercial Execution Services Growth Supply Chain Project Kaizen Delivery Events Excellence Operational Standardization Leverage Operational Excellence 74 Targeted margin expansion over time with initiatives underway to achieve

  75. Slide 75: Capital Structure

    Slide 75: Capital Structure

    Capital Structure Available Credit (C$ millions) Funding $700.0 $656.3 $639.0 $639.1 $629.5 • Extended $750 million credit facility – July 2017 • U.S. $250 million Senior Notes – June 2015 • Support growth strategy • Capacity for increased leverage $0.0 2016 2017 2018 2019 (Q1) Net Cash (Debt)* (C$

  76. Slide 76: Capital Structure – Leverage

    Slide 76: Capital Structure – Leverage

    Capital Structure – Leverage Capitalization 4 1,200 3.5 Peak for acquisitions 1,000 3 $Millions 2.5 Target 800 leverage range 2 600 1.5 1 400 0.5 200 0 - -0.5 Q1 FY17 Q2 FY17 Q3 FY17 Q4 FY17 Q1 FY18 Q2 FY18 Q3 FY18 Q4 FY18 Q1 FY19 Senior Notes Equity Net Debt / Adjusted EBITDA* ratio *Non IFRS measu

  77. Slide 77: ATS Automation – 2018 Investor Day

    Slide 77: ATS Automation – 2018 Investor Day

    ATS AUTOMATION – 2018 INVESTOR DAY - TSX:ATA

  78. Slide 78: Q&A

    Slide 78: Q&A

    ATT | Q&A

  79. Slide 79: Summary

    Slide 79: Summary

    Summary Solid Foundation Strong bookings, growing backlog, healthy balance sheet Solid ATS Foundation Business Model Winning culture comes from People, Process, Performance ATS Business Well Model Positioned Trends include life sciences growth, EV adoption, US reshoring Expanding Services More servi

  80. Slide 80: ATS Automation – 2018 Investor Day

    Slide 80: ATS Automation – 2018 Investor Day

    ATS AUTOMATION – 2018 INVESTOR DAY - TSX:ATA

  81. Slide 81: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Slide 81: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures Notice to reader: Non-IFRS measures and additional IFRS measures Throughout this presentation management uses certain non-IFRS measures to evaluate the performance of the Company. The terms “operating margin”, “EBITDA”, “EBITDA margin”,

  82. Slide 82: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Slide 82: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures C$ millions F2014 F2015 F2016 F2017 F2018 Opening Order Backlog $ 398 $ 474 $ 632 $ 652 $ 681 Revenues (683) (936) (1,040) (1,011) (1,115) Order Bookings 709 981 1,070 1,134 1,182 Order Backlog Adjustments 50 113 (10) (94) (2) Ending Ord

  83. Slide 83: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Slide 83: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures C$ millions FY17 FY18 FY19 Measure Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Adjusted EBITDA 31.5 25.3 26.6 28.5 30.2 32.8 33.3 37.0 36.8 Restructuring charges - - 2.3 - - - 9.0 2.2 - Share purchase allowance - - - 2.9 - - - - - EBITDA 31.5 25.3 24.3 2

  84. Slide 84: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Slide 84: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures C$ millions FY17 FY18 FY19 Measure Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Adjusted earnings from 27.9 22.3 22.5 24.5 26.3 28.8 29.3 32.8 32.6 operations Amortization of 5.3 5.0 4.9 4.8 5.0 4.9 5.5 5.1 5.6 acquisition-related intangible assets Restru

  85. Slide 85: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Slide 85: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures C$ FY17 FY18 FY19 Measure Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Adjusted EPS 0.17 0.13 0.12 0.15 0.16 0.18 0.18 0.22 0.22 Amortization of 0.04 0.04 0.04 0.05 0.04 0.03 0.04 0.04 0.04 acquisition-related intangible assets Restructuring charges - - 0

  86. Slide 86: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Slide 86: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures C$ millions FY17 FY18 FY19 Measure Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Cash and cash 222.5 226.6 203.7 286.7 279.4 306.3 307.6 330.2 324.6 equivalents Bank indebtedness (1.5) (2.1) (1.8) (1.4) (1.0) (1.1) (0.4) (2.7) (2.6) Current portion of long

Source: Internet Archive copy of atsautomation.com

More decks from ATS Corporation

All 38 ATS decks